PI3K/AKT/mTOR Signaling Regulates the Virus/Host Cell Crosstalk in HPV-Positive Cervical Cancer Cells

mTOR: A Cellular Regulator Interface in Health and Disease

(2019) Fahd Boutouja et al.   Cells

Repression of Human Papillomavirus Oncogene Expression under Hypoxia Is Mediated by PI3K/mTORC2/AKT Signaling

(2019) Felicitas Bossler et al.   mBio

Targeting the PI3K pathway in cancer: are we making headway?

(2018) Filip Janku et al.   Nature Reviews Clinical Oncology

PI3K-AKT-mTOR inhibition in cancer immunotherapy, redux

(2018) Jake S. O’Donnell et al.   SEMINARS IN CANCER BIOLOGY

The HPV E6/E7 Oncogenes: Key Factors for Viral Carcinogenesis and Therapeutic Targets

(2018) Karin Hoppe-Seyler et al.   TRENDS IN MICROBIOLOGY

Explanations for the high potency of HPV prophylactic vaccines

(2018) John Schiller et al.   VACCINE

Phase I/II study of the PI3Kβ inhibitor GSK2636771 in combination with pembrolizumab (P) in patients (pts) with PD-1 refractory metastatic melanoma (MM) and PTEN loss.

(2018) Hussein Abdul-Hassan Tawbi et al.   JOURNAL OF CLINICAL ONCOLOGY

Prognostic significance of PIK3CA mutation in stage IIB to IVA cervical cancers treated by concurrent chemoradiotherapy with weekly cisplatin

(2018) Bouchra Lachkar et al.   MEDICINE

Cellular Senescence: The Sought or the Unwanted?

(2018) Yu Sun et al.   TRENDS IN MOLECULAR MEDICINE

Rapamycin, proliferation and geroconversion to senescence

(2018) Mikhail V. Blagosklonny   CELL CYCLE

Inhibition of mTOR Signaling and Clinical Activity of Rapamycin in Head and Neck Cancer in a Window of Opportunity Trial

(2018) Terry A. Day et al.   CLINICAL CANCER RESEARCH

Human papillomavirus and the landscape of secondary genetic alterations in oral cancers

(2018) Maura L. Gillison et al.   GENOME RESEARCH

Immune evasion mechanisms of human papillomavirus: An update

(2017) Alina Steinbach et al.   INTERNATIONAL JOURNAL OF CANCER

The Potential Value of the PI3K/Akt/mTOR Signaling Pathway for Assessing Prognosis in Cervical Cancer and as a Target for Therapy

(2017) Afsane Bahrami et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

Molecular mechanisms underlying human papillomavirus E6 and E7 oncoprotein-induced cell transformation

(2017) Suruchi Mittal et al.   MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH

Induction of dormancy in hypoxic human papillomavirus-positive cancer cells

(2017) Karin Hoppe-Seyler et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Virus/Host Cell Crosstalk in Hypoxic HPV-Positive Cancer Cells

(2017) Karin Hoppe-Seyler et al.   Viruses-Basel

Immunopathogenesis of HPV-Associated Cancers and Prospects for Immunotherapy

(2017) Sigrun Smola   Viruses-Basel

Improving the Armamentarium of PI3K Inhibitors with Isoform-Selective Agents: A New Light in the Darkness

(2017) Jordi Rodon et al.   Cancer Discovery

The PI3K/AKT Pathway as a Target for Cancer Treatment

(2016) Ingrid A. Mayer et al.   Annual Review of Medicine

Overcoming resistance to checkpoint blockade therapy by targeting PI3Kγ in myeloid cells

(2016) Olivier De Henau et al.   NATURE

Hypoxic stress: obstacles and opportunities for innovative immunotherapy of cancer

(2016) S Chouaib et al.   ONCOGENE

pVHL suppresses kinase activity of Akt in a proline-hydroxylation-dependent manner

(2016) J. Guo et al.   SCIENCE

Targeting PI3K in Cancer: Impact on Tumor Cells, Their Protective Stroma, Angiogenesis, and Immunotherapy

(2016) K. Okkenhaug et al.   Cancer Discovery

Current therapeutic vaccination and immunotherapy strategies for HPV-related diseases

(2016) Joseph G. Skeate et al.   Human Vaccines & Immunotherapeutics

Global estimates of human papillomavirus vaccination coverage by region and income level: a pooled analysis

(2016) Laia Bruni et al.   Lancet Global Health

Carcinogenic human papillomavirus infection

(2016) Mark Schiffman et al.   Nature Reviews Disease Primers

Hypoxia: a key player in antitumor immune response. A Review in the Theme: Cellular Responses to Hypoxia

(2015) Muhammad Zaeem Noman et al.   AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY

Prophylactic HPV vaccination: past, present, and future

(2015) P. E. CASTLE et al.   EPIDEMIOLOGY AND INFECTION

Next generation prophylactic human papillomavirus vaccines

(2015) John T Schiller et al.   LANCET ONCOLOGY

Comprehensive genomic characterization of head and neck squamous cell carcinomas

(2015)   NATURE

mTOR regulates MAPKAPK2 translation to control the senescence-associated secretory phenotype

(2015) Nicolás Herranz et al.   NATURE CELL BIOLOGY

MTOR regulates the pro-tumorigenic senescence-associated secretory phenotype by promoting IL1A translation

(2015) Remi-Martin Laberge et al.   NATURE CELL BIOLOGY

PtdIns(3,4,5)P3-Dependent Activation of the mTORC2 Kinase Complex

(2015) P. Liu et al.   Cancer Discovery

Defining normoxia, physoxia and hypoxia in tumours—implications for treatment response

(2014) S R McKeown   BRITISH JOURNAL OF RADIOLOGY

Geroconversion: irreversible step to cellular senescence

(2014) Mikhail V Blagosklonny   CELL CYCLE

Current clinical regulation of PI3K/PTEN/Akt/mTOR signalling in treatment of human cancer

(2014) Hui Jun Lim et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Oxygen Sensing, Hypoxia-Inducible Factors, and Disease Pathophysiology

(2013) Gregg L. Semenza   Annual Review of Pathology-Mechanisms of Disease

Oncogenic mutations in cervical cancer

(2013) Alexi A. Wright et al.   CANCER

Clinical trials of human papillomavirus vaccines and beyond

(2013) Matti Lehtinen et al.   Nature Reviews Clinical Oncology

Aging, Cellular Senescence, and Cancer

(2012) Judith Campisi   Annual Review of Physiology

Activation of AKT by hypoxia: a potential target for hypoxic tumors of the head and neck

(2012) Hanneke Stegeman et al.   BMC CANCER

Pathway-Specific Analysis of Gene Expression Data Identifies the PI3K/Akt Pathway as a Novel Therapeutic Target in Cervical Cancer

(2012) Julie K. Schwarz et al.   CLINICAL CANCER RESEARCH

Tissue biomarkers as prognostic variables of cervical cancer

(2012) Angiolo Gadducci et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

PIK3CA mutational status and overall survival in patients with cervical cancer treated with radical chemoradiotherapy

(2012) John B. McIntyre et al.   GYNECOLOGIC ONCOLOGY

PI3K/AKT/mTOR Inhibitors in Patients With Breast and Gynecologic Malignancies HarboringPIK3CAMutations

(2012) Filip Janku et al.   JOURNAL OF CLINICAL ONCOLOGY

Hypoxia suppresses conversion from proliferative arrest to cellular senescence

(2012) O. V. Leontieva et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Therapy of Human Papillomavirus-Related Disease

(2012) Peter L. Stern et al.   VACCINE

Activation of mTORC2 by Association with the Ribosome

(2011) Vittoria Zinzalla et al.   CELL

Human Papillomaviruses As Therapeutic Targets in Human Cancer

(2011) Karin Hellner et al.   JOURNAL OF CLINICAL ONCOLOGY

Cell-Type-Dependent Regulation of mTORC1 by REDD1 and the Tumor Suppressors TSC1/TSC2 and LKB1 in Response to Hypoxia

(2011) N. C. Wolff et al.   MOLECULAR AND CELLULAR BIOLOGY

PIK3CA-mediated PI3-kinase signalling is essential for HPV-induced transformation in vitro

(2011) Florianne E Henken et al.   Molecular Cancer

PIK3CA Mutations in Patients with Advanced Cancers Treated with PI3K/AKT/mTOR Axis Inhibitors

(2011) F. Janku et al.   MOLECULAR CANCER THERAPEUTICS

Primary human cervical carcinoma cells require human papillomavirus E6 and E7 expression for ongoing proliferation

(2011) Thomas G. Magaldi et al.   VIROLOGY

The Senescence-Associated Secretory Phenotype: The Dark Side of Tumor Suppression

(2010) Jean-Philippe Coppé et al.   Annual Review of Pathology-Mechanisms of Disease

The Human Papillomavirus Type 16 E6 Oncoprotein Activates mTORC1 Signaling and Increases Protein Synthesis

(2010) J. M. Spangle et al.   JOURNAL OF VIROLOGY

Oncogenic activities of human papillomaviruses

(2009) Margaret E. McLaughlin-Drubin et al.   VIRUS RESEARCH

Hypoxia regulates TSC1/2 mTOR signaling and tumor suppression through REDD1-mediated 14 3 3 shuttling

(2008) M. P. DeYoung et al.   GENES & DEVELOPMENT

E6 variants of human papillomavirus 18 differentially modulate the protein kinase B/phosphatidylinositol 3-kinase (akt/PI3K) signaling pathway

(2008) Adriana Contreras-Paredes et al.   VIROLOGY

Expression of an activated mammalian target of rapamycin in adenocarcinoma of the cervix: A potential biomarker and molecular target therapy

(2007) Leri S. Faried et al.   MOLECULAR CARCINOGENESIS